Form 8-K - Current report:
SEC Accession No. 0001437749-25-007032
Filing Date
2025-03-11
Accepted
2025-03-11 16:13:06
Documents
16
Period of Report
2025-03-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K zvra20240918_8k.htm   iXBRL 8-K 35110
2 EXHIBIT 99.1 ex_725374.htm EX-99.1 172565
7 resized1.jpg GRAPHIC 7591
  Complete submission text file 0001437749-25-007032.txt   371577

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA zvra-20250311.xsd EX-101.SCH 3409
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zvra-20250311_def.xml EX-101.DEF 11424
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE zvra-20250311_lab.xml EX-101.LAB 15310
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zvra-20250311_pre.xml EX-101.PRE 11584
18 EXTRACTED XBRL INSTANCE DOCUMENT zvra20240918_8k_htm.xml XML 2848
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
ZEVRA THERAPEUTICS, INC. (Filer) CIK: 0001434647 (see all company filings)

EIN.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36913 | Film No.: 25727730
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)